Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11282231rdf:typepubmed:Citationlld:pubmed
pubmed-article:11282231lifeskim:mentionsumls-concept:C0033095lld:lifeskim
pubmed-article:11282231lifeskim:mentionsumls-concept:C2003864lld:lifeskim
pubmed-article:11282231lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:11282231lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:11282231pubmed:issue1-2lld:pubmed
pubmed-article:11282231pubmed:dateCreated2001-4-3lld:pubmed
pubmed-article:11282231pubmed:abstractTextNanosuspensions produced by high-pressure homogenisation are a solution for the formulation of poorly soluble drugs with bioavailability problems. The typical solid concentration of the nanosuspensions is 10%. However, to transfer the nanosuspensions to a dry product (e.g. granulation, tablets, pellets), a higher solid content is required to remove less water. Nanosuspensions with 20 and 30% solid content were produced, the effect of surfactant concentration assessed and their quality (size data) compared with the lower standard concentrations of 1-10% solid.lld:pubmed
pubmed-article:11282231pubmed:languageenglld:pubmed
pubmed-article:11282231pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11282231pubmed:citationSubsetIMlld:pubmed
pubmed-article:11282231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11282231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11282231pubmed:statusMEDLINElld:pubmed
pubmed-article:11282231pubmed:monthFeblld:pubmed
pubmed-article:11282231pubmed:issn0378-5173lld:pubmed
pubmed-article:11282231pubmed:authorpubmed-author:KrauseK PKPlld:pubmed
pubmed-article:11282231pubmed:authorpubmed-author:MüllerR HRHlld:pubmed
pubmed-article:11282231pubmed:issnTypePrintlld:pubmed
pubmed-article:11282231pubmed:day19lld:pubmed
pubmed-article:11282231pubmed:volume214lld:pubmed
pubmed-article:11282231pubmed:ownerNLMlld:pubmed
pubmed-article:11282231pubmed:authorsCompleteYlld:pubmed
pubmed-article:11282231pubmed:pagination21-4lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:meshHeadingpubmed-meshheading:11282231...lld:pubmed
pubmed-article:11282231pubmed:year2001lld:pubmed
pubmed-article:11282231pubmed:articleTitleProduction and characterisation of highly concentrated nanosuspensions by high pressure homogenisation.lld:pubmed
pubmed-article:11282231pubmed:affiliationDepartment of Pharmaceutics, Biopharmaceutics and Biotechnology, Free University of Berlin, Kelchstrasse 31, 12169 Berlin, Germany.lld:pubmed
pubmed-article:11282231pubmed:publicationTypeJournal Articlelld:pubmed